Dec. 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate ...
("Bionoid") (OTC PINK:BINP) is pleased to provide a corporate update as it looks ... will play a pivotal role in the company's growth strategy. This cutting-edge AI-driven marketing system is ...